Scientists report strong evidence of alterations in blood samples of children with autism
... the disorder. The samples were then analyzed by a biotech company, SurroMed, LLC, Menlo Park, Calif., which has developed technology that can identify differences in the number and types of immune cells, proteins, peptides and metabolites in small amounts of blood. The study has generated an enormous amoun...GM rice will not end hunger in China
... for all, it must look beyond the economic lure of biotech options and focus on meeting the basic needs of the country's poor."...New NIAID grants strengthen national biodefense and emerging infectious diseases research network
... approved investigators from academia, government, biotech companies and the pharmaceutical industry provide facilities and scientific support to first responders in the event of a national biodefense emergency The previously established RCEs in the network are led by Duke University, Harvard Medical Schoo...New base for North American cancer screening pioneers
...nada-based Genesis Genomics (GGUK), a cutting-edge biotech research corporation, is currently developing a new early warning system to aid the effective treatment of skin cancer and skin damaged by sunburn. It plans to use its new base at the University of Newcastle upon Tyne to push the commercial developme...Australians speak: Find us a cure for cancer - fast!
...uals but want government, corporate Australia, the biotech and pharmaceutical industry and charitable foundations to also come to the party," said Dr Bennett. The poll showed the overwhelming majority of Australians (84%) think Australians should have access to the latest medicines, medical devices and clin...American Neurological Association 130th Annual Meeting in San Diego
...tors, highly successful translational researchers, biotech venture capitalists, and entrepreneurs will discuss novel strategies aimed at speeding the journey to treatments. Protecting Nerve Cells in Stroke -- Strokes and other brain injuries starve brain cells of oxygen. Presenters in the Monday afternoon sy...Conference: A long and healthy life: The contribution of medical research to AU community health
...tween life sciences, research, socially beneficial biotech investment and government. 2. Professor Allan McLean, from the National Ageing Research Institute (NARI), Melbourne and Professor Richard Head, from CSIRO, Adelaide, pose the question: Does an ageing population equal an intergenerational opportunity...Australian Cancer Research Foundation announces biggest ever private grant
...sing in different areas, all three agreed that the biotech revolution, combined with the Human Genome project (which enables identification of individual variations in genes), has unleashed huge potential for the prevention and treatment of all types of cancers. Research scientists now have the ability to o...Biotechnology has failed to live up to its promises
...say researchers in this week's BMJ. They assessed biotech products approved by the European Medicine Evaluation Agency between 1995 and 2003. Of 61 products licensed for therapeutic use, only 15 were for diseases without effective treatment, more effective than existing treatment, or active in patients resi...... stated, "With the increasing choice of injectable biotech drugs including monoclonal antibodies, these findings potentially have far reaching implications across a whole range of therapeutic areas. We look forward to presenting the final results and exploring possible interventions at major congresses next ...Florida Tech, FSRI receive $1.3 million federal grant for space research
... their successes in the expansion of aerospace and biotech programs in the state....First two research awards from university-industry partnership
...have sought alternative funding sources, including biotech and pharmaceutical companies. Industry, at the same time, has become more interested in partnering with academic research centers as an efficient source of new ideas. "These awards are crucial because they drive forward truly worthwhile research pro...Warning to government from biotech on PBS changes
Stark warnings that the biotech sector could be damaged and patient health harmed ...ts place among the best in the world as a home for biotech and clinical trials."...Columbia receives up to $15 million from Spinal Muscular Atrophy Foundation
...ion to researchers at academic medical centers and biotech companies. The grant to the Center for Motor Neuron Biology and Disease is meant to unite, consolidate and amplify previous funding for SMA research and clinical efforts at Columbia University. These include: The SMA Clinic at Columbia University Med...Public support for science and innovation: Productivity Commission report
... in clinical trials and support for areas like new biotech medicines and vaccines. "The pharmaceutical industry, with almost $3 billion in exports, is now the second largest exporter of manufactured products after the automotive industry. "The launch of new medicines over the past 30 years is also responsibl...Industry welcomes massive Victorian investment in medical research
... with the Victorian government to build Victoria's biotech industries," Tim Murphy says....New hope in cancer vaccines emerges as novel therapies are developed and tested
...logist who came to M. D. Anderson in 2002 from the biotech and pharmaceutical industry, and Jeffrey Molldrem,...e, now known as Biovaxid after being licensed to a biotech firm by NCI, is now being tested in a national phase III clinical trial. This study, led at M. D. An...Cardiologist's 'living chip' changes science of disease monitoring
...oward reality at Physiologic Communications LLC, a biotech company founded by University of Rochester Medical Center cardiologist Spencer Rosero, M.D., who specializes in heart rhythm disorders. The company is developing implantable biosensors integrating living cells with electronics to create a "biologic...Researchers seek to design first treatment for neuroAIDS
...hibitor, CEP-1347, developed by Pennsylvania-based biotech Cephalon. Ira Shoulson, M.D., professor of Neurology at the University of Rochester Medical Center, had served as an auditor of Cephalon's PRECEPT trial, where CEP-1347 was tested as a treatment for Parkinson's disease. He proposed that Cephalon mak......d tissue was sent to Antigenics, the Massachusetts biotech company that produces the vaccine from the patient's tumor tissue. Because of the size of the tumor, Hekkala will receive injections every other week until mid-February. So far, results are promising with no sign of tumor regrowth, according to the P...